Anti-IgE-antikörper und spezifische immuntherapie (SIT)

Translated title of the contribution: Combination of omalizumab (anti-IgE) and specific immunotherapy (SIT)

M. V. Kopp*

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Combination of omalizumab (anti-IgE) and specific immunotherapy (SIT)'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science